Omne Possibile released to harness transformative power of

Omne Possibile launched to harness transformative electric power of XNA in healthcare, data technologies and

Omne Possibile launched to harness transformative electric power of XNA in healthcare, data technologies and wise supplies

A groundbreaking, worldwide technological chief in XNA developing customizable buildings to outperform current DNA and RNA technologies

XNA is at the forefront of the artificial biology revolution, forecast to remodel drugs, agriculture, electrical power, buyer merchandise and IT with a $4 trillion once-a-year financial effects

Started by major European synthetic biologists

Leuven, Belgium, and Basel, Switzerland 10 May well 2021: Omne Possibile (“the Company”), a international artificial biology enterprise pioneering the XNA revolution, has been launched now to harness the ability of XNA (xeno nucleic acids) to completely transform medicine, agriculture, electrical power, buyer goods and facts engineering. XNA is at the forefront of the artificial biology revolution, made to defeat the constraints of the chemical structures of DNA and RNA technologies. It is forecast to have a $4 trillion once-a-year financial effects over the subsequent 10 to 20 many years, increased than that of the net.1

Patrice Garnier, President and Chief Govt Officer of Omne Possibile, explained: “Synthetic biology has been called the fifth industrial revolution. We believe that XNA will be the dominant technology of the 21st century, with a profound impact on all areas of our everyday life like health care, information and facts engineering, vitality, transportation and buyer merchandise. Omne Possibile unites major European gurus in the essential making blocks of synthetic biology and the critical disciplines of XNA growth. Our ambition is to change Europe’s advancements in XNA technological innovation into a international business that will lead the revolution in synthetic genetics.”

“Xenobiology will be to biology what astronautics has been to astronomy.” adds Philippe Marlière, Chairman of the Board of Omne Possibile. “Via the diversification of the base alphabet and backbone motifs of DNA and RNA analogs, our company will offer the sector with a plethora of tailored genetic polymers. Acquiring introduced jointly the most forward-contemplating researchers and industrialists in the subject, like two Nobel laureates, Omne Possibile is set to provide genetic polymers to market place.”

Omne Possibile was co-founded by Patrice Garnier, an entrepreneur with additional than 20 years of working experience primary substantial-tech corporations, Alexandre Mouradian, a seasoned and visionary trader, and by a few of Europe’s primary artificial biologists: Philippe Marlière, Scientific Director at ISSB Evry Piet Herdewijn, Professor of Medicinal Chemistry at KU Leuven Sven Panke, Professor of Bioprocess Engineering at ETH Zürich.

The Enterprise will at first emphasis on advancement of XNA polymers for details storage and XNA constructing blocks for improved messenger therapeutics:

  • Storage XNA (sXNA) are observed as perfect candidates to deal with the exponential advancement of info in the coming decades, providing rewards in phrases of ability, electricity use, space demands and cost.
  • Messenger XNA (mXNA) is built to conquer the limitations of mRNA, the backbone of present day vaccine technologies in spots like viral bacterial infections and cancer. They also engage in vital roles in genetic treatments and in agricultural pest management. mXNA provides the opportunity for enormously enhanced chemical functionality and biological stability, opening up considerable new chances in health care and other fields.

Omne Possibile brings together the essential disciplines of XNA growth, including chemical synthesis, genetics, directed evolution of enzymes and genomes, automatic layout of molecules, and bioproduction pathways. It has founded an R&D innovation center in Leuven, Belgium, to concentration on XNA chemistry, and a next R&D hub in Basel, Switzerland, focused to XNA genetics. It intends to expand quickly via a combination of in-house development and industrial collaborations.

A scientific advisory board of foremost industrialists and globally renowned researchers will be declared in the up coming couple weeks to manual the Company’s method.


About Omne Possibile

Omne Possibile is a revolutionary, world technological chief in XNA, generating customizable constructions to outperform recent DNA and RNA systems. Its purpose is to harness the transformative energy of XNA in locations together with health care, information and facts know-how and good components. The Company’s first aim is on advancement of XNA polymers for data storage and XNA building blocks for enhanced messenger therapeutics. Omne Possibile has R&D hubs in Leuven, Belgium, and Basel, Switzerland. It was started by major European artificial biologists and is supported by a entire world course scientific advisory board. For much more details, remember to take a look at

Get in touch with

Omne Possibile
Patrice Garnier, Chief Government Officer
[email protected]

Consilium Strategic Communications
Amber Fennell, Jonathan Birt, Melissa Gardiner, Carina Jurs
+44 () 203 709 5000
[email protected]

1 How the Bio Revolution could rework the aggressive landscape, Michael Chui, Matthias Evers, Alice Zheng, McKinsey Quarterly, Could 2020